EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Banxia Shumi Decoction Alleviates PCPA ‐Induced Insomnia and Regulates ADAM10 Expression via Melatonin Signaling in Rats

Banxia Shumi Decoction lindert PCPA-induzierte Insomnie und reguliert ADAM10-Expression über Melatonin-Signalisierung bei Ratten

Baojun Guo, Yuqin Tang iD, Yongqiang Zhang iD, Yeke Wu, Ranran Gao

CNS Neuroscience & Therapeutics · 2026-09 · 32 (9)

DOI: 10.1002/cns.70988 ↗

Auf einen Blick

In einem Rattenmodell verbesserte Banxia Shumi Decoction die Insomnie: Die Schlaflatenz war kürzer, die Schlafdauer länger. Der Effekt war mit veränderten Melatonin- und Zielmolekül-Spiegeln verbunden.

Fragestellung

Welche Wirkung hat Banxia Shumi Decoction bei PCPA-induzierter Insomnie bei Ratten und über welchen Mechanismus wirkt sie?

Methode

Rattenmodell der Insomnie durch 4-Chloro-DL-phenylalanine; Analysen mit ELISA, qRT-PCR, Western blot und IHC in SCN, Hippocampus und Serum; luzindole zur Prüfung des Mechanismus.

Ergebnisse

Im Vergleich zur Modellgruppe verkürzte BXSMD die Schlaflatenz und verlängerte die Schlafdauer. 5-HT, MT und MT1/MT2 stiegen; CLOCK, PER1, CaMKII, GABARAP und ADAM10 wurden hochreguliert, mGLuR1 herunterreguliert.

Schlussfolgerung der Autor:innen

BXSMD lindert PCPA-induzierte Insomnie bei Ratten. Der Mechanismus beruht laut Autor:innen auf MT1/MT2 als Kernzielen und der Regulation schlafbezogener Moleküle sowie ADAM10.

Kernaussagen

  • Schlaflatenz kürzer, Schlafdauer länger unter BXSMD
  • 5-HT, MT und MT1/MT2 nahmen zu
  • Luzindole hob die Effekte von BXSMD auf alle veränderten Moleküle auf

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 20.09.2026. Verfasst von Baojun Guo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of TCM, Henan Provincial People's Hospital, Zhengzhou University, Zhengzhou, Henan, China. Hauptthemen laut MEDLINE: ADAM10 Protein, Sleep Initiation and Maintenance Disorders, Melatonin, Membrane Proteins. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Postdoctoral Research Project in Henan Province, National Natural Science Foundation of China, Natural Science Foundation of Sichuan Province.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Insomnia is a pathological sleep disorder marked by persistent sleep‐onset difficulties. This study explored the therapeutic effects and underlying mechanism of Banxia Shumi Decoction (BXSMD) in treating insomnia.

Methods

This study used network pharmacology to predict the core targets and signaling pathways of BXSMD in insomnia intervention. A rat insomnia model was constructed via 4‐Chloro‐DL‐phenylalanine (PCPA) to assess BXSMD's behavioral impacts. ELISA, qRT‐PCR, Western blot, and IHC were applied to detect the expression of 5‐hydroxytryptamine (5‐HT), melatonin (MT), MT1/MT2 receptors, and related factors (CLOCK, PER1, CaMKII, p‐CREB/CREB, GABARAP, mGLuR1, ADAM10) in the rat suprachiasmatic nucleus (SCN), hippocampus, and serum. The non‐selective melatonin receptor antagonist luzindole was administered to explore its influence on BXSMD‐regulated expression of the above molecules.

Results

Compared with the model group, the BXSMD group showed shortened sleep latency and prolonged sleep duration. BXSMD significantly elevated 5‐HT, MT, and MT1/MT2 levels. BXSMD upregulated the mRNA and protein expression of downstream effector molecules including CLOCK, PER1, CaMKII, and GABARAP, downregulated mGLuR1 expression, and increased the expression of ADAM10. Notably, CREB mRNA expression remained unchanged, while BXSMD significantly increased the p‐CREB/CREB protein ratio. The regulatory effects of BXSMD on all altered molecules were significantly reversed by luzindole.

Conclusion

BXSMD effectively alleviates PCPA‐induced insomnia in rats. The mechanism relies on MT1/MT2 as core targets, which mediate the regulation of sleep‐related molecules (CLOCK, PER1, CaMKII, p‐CREB/CREB, GABARAP, and mGluR1), as well as the membrane protein shedding‐related molecule ADAM10.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ADAM10 ProteinSleep Initiation and Maintenance DisordersMelatoninMembrane ProteinsAmyloid Precursor Protein SecretasesDrugs, Chinese HerbalAnimalsMaleSignal TransductionRatsRats, Sprague-DawleyDisease Models, Animal

Stichwörter der Autor:innen

ADAM10Banxia Shumi decoctioninsomniamelatoninnetwork pharmacology

Substanzen

ADAM10 ProteinMelatoninADAM10 protein, ratMembrane ProteinsAmyloid Precursor Protein SecretasesDrugs, Chinese Herbal

Autor:innen und Institutionen

  • Department of TCM, Henan Provincial People's Hospital, Zhengzhou University, Zhengzhou, Henan, China.
  • Clinical Bioinformatics Experimental Center, Henan Provincial People's Hospital, Zhengzhou University, Zhengzhou, Henan, China.
  • Henan Academy of Innovations in Medical Science, Henan Academy of Medical Sciences, Zhengzhou, Henan, China.
  • Department of Stomatology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.

ORCID-Profile: Yuqin Tang, Yongqiang Zhang

Förderung

  • Postdoctoral Research Project in Henan Province
  • National Natural Science Foundation of China
  • Natural Science Foundation of Sichuan Province
  • Henan Province Postdoctoral Research Program
  • Health Commission of Chengdu and Chengdu University of Traditional Chinese Medicine Joint Innovation Fund in 2024

Zitieren

APA

Guo, B., Tang, Y., Zhang, Y., Wu, Y., & Gao, R. (2026). Banxia Shumi Decoction Alleviates PCPA ‐Induced Insomnia and Regulates ADAM10 Expression via Melatonin Signaling in Rats. CNS Neuroscience & Therapeutics, 32(9). https://doi.org/10.1002/cns.70988

Vancouver

Guo B, Tang Y, Zhang Y, Wu Y, Gao R. Banxia Shumi Decoction Alleviates PCPA ‐Induced Insomnia and Regulates ADAM10 Expression via Melatonin Signaling in Rats. CNS Neuroscience & Therapeutics. 2026;32(9). doi:10.1002/cns.70988

BibTeX
@article{Guo2026,
  author = {Guo, Baojun and Tang, Yuqin and Zhang, Yongqiang and Wu, Yeke and Gao, Ranran},
  title = {Banxia Shumi Decoction Alleviates PCPA ‐Induced Insomnia and Regulates ADAM10 Expression via Melatonin Signaling in Rats},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2026},
  volume = {32},
  number = {9},
  doi = {10.1002/cns.70988}
}
Kostenlos starten →